Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Jacobio racks up $174m in IPO

Lilly Asia Ventures achieved an exit in a Hong Kong offering in which the oncology therapy developer floated at the top of its range.


Dec 31, 2020

Flexiv assembles $100m series B

Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.

Dec 31, 2020

Cothera catches $30m in series B

Legend Star and CMB International are among the participants in the cancer drug developer’s latest round, which was led by Tsing Song Capital.

Dec 30, 2020

QD Laser points to IPO

Axa Life, Dai-ichi Life, Digital Garage, Fujitsu, Intage, Mitsui, MTG, Nikon, NTT Docomo and Tokyo Century are all set to exit the semiconductor laser provider in an offering on TSE.

Dec 30, 2020

Tencent deepens DXY investment in $500m round

Tencent Investment was among the participants in late-stage round for the online medical information and social networking service.

Dec 30, 2020

Graphcore grafts on $222m

The intelligent chipmaker, which counts Microsoft, Samsung, BMW, Robert Bosch and Dell as investors, secured series E funding at a $2.77bn valuation.

Dec 30, 2020

Uniontech bonds with series A investors

The Archermind-backed operating system developer was reportedly valued at $734m valuation in a $168m round led by Beijing E-Town.

Dec 30, 2020

Meishubao crafts $210m series D round

Bojia Capital reinvested in the Tencent-backed online arts education provider in a round that pushed its overall funding to $305m.

Dec 30, 2020

Transcenta triggers $105m crossover round

Lilly Asia Ventures has put more funding into Transcenta to help sustain the antibody drug developer's clinical-stage pipeline.

Dec 30, 2020

HelpSystems validates Vera purchase

Capital One Ventures was among the exiting investors at data protection software provider Vera, which had raised $50m pre-acquisition.

Dec 30, 2020

Aivita completes $25m series B-2 round

The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.

Dec 30, 2020

Graphcore grafts on $222m

The intelligent chipmaker, which traces its roots back to University of Bristol, has secured series E funding at a $2.77bn valuation.

Dec 30, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here